Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Product sales $ 4 $ 173
Operating cost and expense    
Plant operations and clean up 3,959 7,017
Research and development cost 1,813 933
General and administrative expense 9,815 9,688
Total operating expense 15,587 17,638
Loss from operations (15,583) (17,465)
Other income and expense    
Insurance proceeds net of related expenses 0 4,794
Impairment expense (579) (545)
PPP loan forgiveness 0 332
Gain (loss) on disposal of property and equipment 596 (5,665)
Interest expense (125) (21)
Interest and other income 262 379
Total other income (expense), net 154 (726)
Loss before income tax expense (15,429) (18,191)
Income tax expense (2) (2)
Net loss $ (15,431) $ (18,193)
Weighted average shares outstanding, basic and diluted (in shares) 75,811,034 70,002,180
Basic and diluted net loss per share (in dollars per share) $ (0.20) $ (0.26)